Skip to main content

FDA recall, , Moderate risk

Medos International Velys Enabling Tech Robotic-Assist Station

The Velys Enabling Tech Robotic-Assist Station has a software issue that may cause unintended movement of the robotic arm.

What happened

Medos International Sarl, based in Le Locle, Switzerland, began a recall of the Velys Enabling Tech Robotic-Assist Station REF: 451611001 on July 23, 2026, due to a software issue within the robotic controller that may cause unintended movement of the robotic arm during bone preparation or instrument positioning. The recall involves 29 stations and was added to the FDA's Enforcement Report on September 2, 2026.

The stations were distributed nationwide in the US states of Delaware, Florida, Illinois, Kentucky, Maryland, Michigan, Minnesota, New Jersey, New Mexico, New York, Oregon, Pennsylvania, Tennessee, Texas, Virginia, and Washington.

What to do

We don't have product-specific instructions for this recall. FDA's general advice for medical device recalls:

  1. A device recall doesn't always mean you must stop using it: it may need to be checked, adjusted or fixed.
  2. Talk to your health care provider before you stop using it.

Is yours affected?

Affected if its UDI-DI matches.

A UDI-DI is the device identifier printed with the barcode on the device label.

  1. Velys Enabling Tech Robotic-Assist Station REF: 451611001

    UDI-DI
    • 10705034645995

Recall details

Company began the recall
Company
Medos International SarlLe Locle, Switzerland
Risk

Moderate risk

Using it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.

FDA Class II recall · How risk is rated

Event ID
99467
Recall number
Z-3088-2026
Quantity recalled
29 stations

Timeline

FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.

  1. Company began the recall

  2. Added to FDA's Enforcement Report · Classified by FDA

  3. Listed on Recall Canary

  4. In FDA's weekly enforcement report

  5. Summary updated

Summary by Recall Canary, written with AI · summary updated Oct 25, 2026 · primary source: U.S. Food and Drug Administration (opens in a new tab)